Skip to content

Study of TMS for enhancing recovery of function after acute stroke. (TRYST)

Transcranial magnetic stimulation for enhancing recovery of function after acute stroke.(TRYST) - TRYST

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023487
Enrollment
60
Registered
2020-02-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G819- Hemiplegia, unspecified

Interventions

Intervention1: repetitive Transcranial Magnetic Stimulation: Machine: The rTMS machine used will be NeuroSoft MS-D. Coil: Flat or Curved Circular Coil with a diameter of 15cm will be used. Physical Th

Sponsors

Investigator initiated
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. First episode of acute hemispheric stroke (infarct or bleed) as established on neuroimaging 2. Age 18 - 80 years 3. Day 3 â?? 15 from onset of stroke symptoms, 4. NIH arm motor score >1 5. Stable GCS greater than or equal to 8 and off ventilator for 48 hours

Exclusion criteria

Exclusion criteria: 1 Patients with major cognitive deficits/spasticity / contracture/limb deformities interfering with study participation. 2. Epilepsy, psychosis, delirium. 3. Patients who received Intravenous or Intra-arterial tissue plasminogen activator or thrombectomy 4. Concomitant acute Myocardial Infarction, pulmonary embolism or Deep Venous Thrombosis 5. Hemodynamic instability 6. Major cardiac, renal, hepatic or pulmonary dysfunction 7. Uncontrolled sepsis 8. Trauma-orthopedic injury that limits the range of motion of the upper limb 9. Contraindications to TMS like intracranial metallic implants, cardiac implants, pacemakers 10. Pregnancy or likely to become pregnant during the study period. 11. Patients with stroke associated with CNS infections, HIV, malignancy, haemopoetic disorders 12. Premorbid MRS score- greater than 2 13. Not willing to consent

Design outcomes

Primary

MeasureTime frame
Improvement in FMA-UE(Fugl Meyer Assessment-Upper extremity) scoreTimepoint: 3 months

Secondary

MeasureTime frame
MAS (modified ashworth score), ARAT (action research arm test) and MRS (modified rankin scores)Timepoint: 3 months

Countries

India

Contacts

Public ContactDr Pawan Ojha

Grant Medical College, JJ Group of Hospitals

ptojha@yahoo.co.in9820523745

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026